Mattei Spagyric Bioscience Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 4 Months
About Mattei Spagyric Bioscience
Mattei Spagyric Bioscience Private Limited (MSBPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 September 2018 (Six years and four months 21 days old ). Its registered office is in Patiala, Punjab, India.
The Company is engaged in the Manufacturing Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajinder Aulakh and Veerpal Dhaliwal serve as directors at the Company.
Company Details
-
Location
Patiala, Punjab, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U36999PB2018PTC048430
-
Company No.
048430
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Sep 2018
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
What products or services does Mattei Spagyric Bioscience Private Limited offer?
Mattei Spagyric Bioscience Private Limited offers a wide range of products and services, including Graduation & High Education Programs, Medical Educational Service, Medical Surgery & Treatment Centres, Medical Treatment Services.
Who are the key members and board of directors at Mattei Spagyric Bioscience?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajinder Aulakh
|
Director | 26-Sep-2018 | Current |
|
Veerpal Dhaliwal
|
Director | 26-Sep-2018 | Current |
Financial Performance of Mattei Spagyric Bioscience.
Enhance accessibility to Mattei Spagyric Bioscience's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mattei Spagyric Bioscience?
Unlock access to Mattei Spagyric Bioscience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Ozia Lifewell Private LimitedRajinder Aulakh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mattei Spagyric Bioscience?
Unlock and access historical data on people associated with Mattei Spagyric Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mattei Spagyric Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mattei Spagyric Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.